首页> 外国专利> Amino-peptidase and bleomycin hydrolase inhibitor bestatin - produced by aerobic cultivation op Streptomyces strains e.g. strain MD976-C7

Amino-peptidase and bleomycin hydrolase inhibitor bestatin - produced by aerobic cultivation op Streptomyces strains e.g. strain MD976-C7

机译:氨基肽酶和博来霉素水解酶抑制剂Bestatin-通过链霉菌菌株的有氧培养产生的。菌株MD976-C7

摘要

Bestatin of formula (I) and its acidic salts are new. Bestatin is produced by cultivation of a bestatin-producing Streptomyces in a C- and N-contg. nutrient medium under aerobic conditions. Bestatin has substantially no antibacterial activity, but it shows weak inhibition of cell (including tumour cell) growth in mammals and strong inhibition of aminopeptidase B, leucine aminopeptidase and bleomycin hydrolase. On account of its inhibition of bleomycin hydrolase, bestatin strongly synergizes the antitumour effect of bleomycin. It can therefore be used in combination with bleomycin for the treatment of squamous cell carcinoma, and in the analysis of biological functions and disease processes.
机译:式(I)的Bestatin及其酸性盐是新的。通过在C-和N-contg中培养产生bestatin的链霉菌来产生Bestatin。有氧条件下的营养培养基。 Bestatin基本上不具有抗菌活性,但是在哺乳动物中对细胞(包括肿瘤细胞)生长的抑制作用较弱,对氨基肽酶B,亮氨酸氨基肽酶和博来霉素水解酶的抑制作用较强。由于其抑制博来霉素水解酶,因此bestatin强烈地增强了博来霉素的抗肿瘤作用。因此,它可以与博来霉素联合用于治疗鳞状细胞癌,以及用于分析生物学功能和疾病过程。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号